On 29 January 2026, ADDvise Group AB (publ) (“ADDvise”) announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market (“First North”) in accordance with the request from Amplex AB, which in connection with its public offer has become the owner of … Read more
On 10 December 2025, Amplex AB (“Amplex”), announced a public offer (the “Offer”) to the holders of shares and warrants of ADDvise Group AB (publ) (“ADDvise”). On 27 January 2026, Amplex announced that the Offer had been accepted to such extent that Amplex will become the owner of 94.31 per cent of all shares in … Read more
On 10 December 2025, Amplex AB (“Amplex” or the “Bidder”) announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) (“ADDvise” or the “Company”) to transfer all their shares and warrants in the Company to Amplex (the “Offer”). To provide shareholders and warrant holders in ADDvise with the necessary … Read more
ADDvise Group AB (publ) (the “Company” or “ADDvise”) announces that the Company has received the bondholders’ approval of the proposed amendments in the written procedure under the terms and conditions of the Company’s outstanding bonds 2025/2028 with ISIN SE0025011885 (the “Bonds”) that was initiated on 2 January 2026 (the “Written Procedure”). The Written Procedure was … Read more
ADDvise Group AB (publ) (the “Company” or “ADDvise”) has instructed the agent under the Company’s outstanding bonds 2025/2028 with ISIN SE0025011885 (the “Bonds”) to initiate a written procedure in which the Company requests that the bondholders approve certain amendments to the terms and conditions of the Bonds (the “Written Procedure”). The proposed amendments in the … Read more
ADDvise Group’s subsidiary MRC Systems has received an order from IPS. IPS are a global engineering firm that delivers complex projects within life science. The order is worth approximately USD 2.3 million. The order involves design, paneling, and installation of a cleanroom and associated accessories for a new pharmaceutical manufacturing facility located in the United … Read more
In accordance with the resolution at the Annual General Meeting 2022 of ADDvise Group, the nomination committee for the Annual General Meeting 2026 shall comprise of representatives of the three largest shareholders by votes, according to the shareholders’ register as of 30 June 2025 maintained by Euroclear Sweden, and of the chairman of the board … Read more
ADDvise Group publishes its interim report January 1 – September 30, 2025 on Thursday, October 23, 2025 at 7.45 am (CET). Media, investors and analysts are invited to attend a webcast and teleconference on the same day at 14:00 (CET). CEO, Staffan Torstensson, and CFO, Johan Irwe, will present the report. WebcastIf you wish to … Read more